| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $31.69M | - | |
| VP | 141.5K | $11.21M | - | |
| Other | 87.3K | $6.91M | - | |
| VP | 73.6K | $5.82M | -15,000 | |
| CFO | 70.1K | $5.55M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $36.18 | $72,360.00 | -1.4% | -3.5% | +90.3% | |
| Apr 7, 2025 | Callos Andrew | EVP, Chief Commercial Officer | Sell | 2,886 | $35.78 | $103,261.08 | -4.3% | -7.3% | +81.9% | |
| Apr 3, 2025 | Harrington Robert Arthur51 | Director | Sell | 450 | $39.43 | $17,743.50 | -3.0% | -15.2% | +64.7% | |
| Mar 31, 2025 | Blum Robert I51 | President &CEO | Sell | 15,000 | $40.75 | $611,250.00 | -3.4% | -17.8% | +64.0% | |
| Mar 18, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 2,000 | $43.58 | $87,160.00 | -1.4% | -22.0% | +43.7% | |
| Mar 17, 2025 | Malik Fady Ibraham55 | EVP Research &Development | Sell | 4,389 | $44.38 | $194,783.82 | -4.2% | -24.8% | +38.3% | |
| Mar 17, 2025 | Blum Robert I51 | President &CEO | Sell | 12,648 | $44.38 | $561,318.24 | -3.7% | -24.8% | +38.3% | |
| Mar 17, 2025 | Blum Robert I51 | President &CEO | Sell | 25,000 | $44.65 | $1,116,250.00 | -6.9% | -24.8% | +38.3% | |
| Mar 17, 2025 | Callos Andrew | EVP, Chief Commercial Officer | Sell | 2,775 | $44.38 | $123,154.50 | -7.4% | -24.8% | +38.3% | |
| Mar 17, 2025 | Callos Andrew | EVP, Chief Commercial Officer | Sale+OE | 20,900 | $45.14 | $943,426.00 | -35.7% | -24.8% | +38.3% |